申请人:Olema Pharmaceuticals, Inc.
公开号:US08063249B1
公开(公告)日:2011-11-22
The present invention is directed to compounds, compositions thereof, and the use of the compounds and compositions for the treatment and prevention of breast cancer. In one embodiment, the present invention relates to the use of a substituted triphenyl butene or prodrug thereof for the treatment of breast cancer in mono-therapy or in combination therapy, or for a reduction in the recurrence rate of previously-treated breast cancer.
本发明涉及化合物、其组合物及其在乳腺癌治疗和预防中的应用。在一种实施方案中,本发明涉及使用取代的三苯基丁烯或其前药单独或联合治疗乳腺癌,或减少先前治疗过的乳腺癌的复发率。